Literature DB >> 1100626

Inactivation of normal beta-D-galactosidase by antibodies to defective forms of the enzyme.

R A Roth, B Rotman.   

Abstract

A counterpart of the antibody-mediated activation of genetically defective enzymes is reported here. Antibodies elicited by certain mutant forms of beta-D-galactosidase (EC 3.2.1.23) of Escherichia coli were found to inactivate the normal form of the enzyme. (Antibodies elicited by normal beta-D-galactosidase do not affect the enzyme's catalytic activity.) We present evidence that the inactivating antibodies are directed against one or a few determinants of the enzyme. The level of inactivation caused by the antibodies was independent of temperature below 25 degrees and increased with temperature above 25 degrees. The inactivation was proportional to the concentration of antiserum until a maximum level of 50% inactivation was reached. Antibodies capable of inactivating up to 87% of the activity were obtained after the antiserum was partially absorbed in an affinity column. This antibody preparation showed a 10-fold enrichment of inactivating antibodies over other antibodies direct against the enzyme. The antibody-mediated inactivation caused a reduction in the Vmax of beta-D-galactosidase without affecting the apparent Km of the enzyme. In contrast to antibodies to normal beta-D-galactosidase, inactivating antibodies changed the response of the enzyme to cations. To explain these results, we present a model in which there is a temperature-dependent equilibrium between two active forms of beta-D-galactosidase. Inactivation results from a conformational change induced by the binding of inactivating antibodies to only one of these two forms.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100626

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Antibody-mediated activation of a defective beta-D-galactosidase: dimeric form of the activatable mutant enzyme.

Authors:  E Conway de Macario; J Ellis; R Guzman; B Rotman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  Production of monoclonal antibodies to islet cell surface antigens using hybridization of spleen lymphocytes from non-obese diabetic mice.

Authors:  K Yokono; K Shii; J Hari; S Yaso; Y Imamura; K Ejiri; K Ishihara; S Fujii; T Kazumi; H Taniguchi
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

3.  Activation of beta-galactosidase by monoclonal antibodies.

Authors:  R J Duncan; J Hewitt; P D Weston
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

4.  Antibody-mediated activation of genetically defective Escherichia coli beta-galactosidases by monoclonal antibodies produced by somatic cell hybrids.

Authors:  R S Accolla; R Cina; E Montesoro; F Celada
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

Review 5.  Antibody-mediated enzyme formation: Its legacy at age fifty-four.

Authors:  Roberto Strom; Franco Celada
Journal:  J Mol Recognit       Date:  2021-10-24       Impact factor: 2.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.